Φορτώνει......
BCL2 as a Subtype-Specific Prognostic Marker for Breast Cancer
PURPOSE: B-cell lymphoma 2 (BCL2) is an antiapoptosis protein and an important clinical breast cancer prognostic marker. As the role of BCL2 is dependent on the estrogen receptor (ER) status, this effect might differ according to molecular subtypes. The aim of this study was to evaluate the relation...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Breast Cancer |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Korean Breast Cancer Society
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5053309/ https://ncbi.nlm.nih.gov/pubmed/27721874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2016.19.3.252 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|